Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 24;39(26):2859–2871. doi: 10.1200/JCO.20.03060

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by American Society of Clinical Oncology

Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

FIG A7. — CDKN2A and association with survival. (A) EFS and OS by CDKN2A deletion in the COG cohort (blue) and the UK cohort (orange). (B) EFS and OS by CDKN2A status after removal of any cases with a co-occurring mutation of MYOD1: COG cohort (blue) and UK cohort (orange). (C) EFS within the COG cohort demonstrated that the observed effect of CDKN2A alteration was largely within the intermediate-risk group. BH adj, Benjamini-Hochberg–adjusted; COG, Children's Oncology Group; EFS, event-free survival; HR, hazard ratio; Mut, mutated; OS, overall survival; WT, wild type.